Trials / Conditions / Hormone Receptor Positive Breast Neoplasms
Hormone Receptor Positive Breast Neoplasms
3 registered clinical trials studyying Hormone Receptor Positive Breast Neoplasms — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advan NCT06805812 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | — |
| Terminated | A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors NCT05194072 | Seagen, a wholly owned subsidiary of Pfizer | Phase 1 |
| Completed | A Safety Study of SGN-LIV1A in Breast Cancer Patients NCT01969643 | Seagen Inc. | Phase 1 |